Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [21] Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA
    Yao, Ji-Jin
    Lin, Li
    Jin, Ya-Nan
    Wang, Si-Yang
    Zhang, Wang-Jian
    Zhang, Fan
    Zhou, Guan-Qun
    Cheng, Zhi-Bin
    Qi, Zhen-Yu
    Sun, Ying
    CANCER SCIENCE, 2017, 108 (08) : 1640 - 1646
  • [22] EPSTEIN-BARR VIRUS INDUCES VIRAL NUCLEAR ANTIGEN IN NASOPHARYNGEAL EPITHELIAL-CELLS
    DESGRANGES, C
    DETHE, G
    LANCET, 1977, 2 (8051): : 1286 - 1287
  • [23] Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis
    Javier S. Burgos
    Medical Oncology, 2005, 22 : 113 - 121
  • [24] Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma
    Wong, MMF
    Lye, MS
    Cheng, HM
    Sam, CK
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2005, 23 (01): : 65 - 67
  • [25] Role of Epstein-Barr virus gene latent membrane protein in nasopharyngeal carcinoma
    Nicholson, LJ
    Morris, JDH
    TRENDS IN MICROBIOLOGY, 1996, 4 (04) : 132 - 133
  • [26] EPSTEIN-BARR VIRUS SEROEPIDEMIOLOGY IN NASOPHARYNGEAL CARCINOMA IN ALGERIA
    ABLASHI, DV
    ALLAL, L
    ARMSTRONG, G
    BOUGUERMOUH, A
    PEARSON, G
    LEVINE, PH
    BENGALI, Z
    EASTON, JM
    ZAGHOUANI, S
    CHOUITER, A
    ALLOUACHE, A
    GHOUADLI, R
    HEAD & NECK SURGERY, 1981, 3 (03): : 257 - 258
  • [27] Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
    Niedobitek, G
    PATHOLOGE, 1998, 19 (05): : 337 - 344
  • [28] The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    You Quan Li
    Ni Sann Khin
    Melvin LKChua
    Cancer Biology & Medicine, 2018, 15 (01) : 1 - 5
  • [29] Nasopharyngeal carcinoma - Epstein-Barr virus serologic testing
    Neel, HB
    HEAD AND NECK CANCER, VOL 4, 1996, : 572 - 577
  • [30] EPSTEIN-BARR VIRUS SEROLOGY IN THE CONTROL OF NASOPHARYNGEAL CARCINOMA
    LEVINE, PH
    CONNELLY, RR
    MILMAN, G
    EASTON, J
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 357 - 362